Rethinking how we estimate lung deposition

A patient completes a nebulized treatment.

• The device performs as expected.
• The dose is prepared correctly.

❓But how much of the drug actually reached the lungs?
❓And where did it deposit?

In inhaled therapies, lung deposition is rarely measured directly.
It is typically inferred using standardised breathing profiles — despite the fact that real patients rarely breathe in a “standard” way.

💡The Kolibri™ Mesh Nebulizer collects real breathing data during nebulization, capturing how a patient actually breathes throughout the treatment.

These real breathing profiles are then used as input for lung deposition models, enabling estimation of:
➡️ Delivered lung dose
➡️ Regional deposition within the lungs

From nebulization to lung deposition — connected.

This is the idea behind APEX.

🔍 Coming soon.